CbsBioscience Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 1

CbsBioscience General Information

Description

Operator of a big data and artificial intelligence-based precision medical company intended to provide customized medical services tailored to the characteristics of patients. The company provides prognosis prediction, anticancer drug companion, diagnosis technology development, and biomarker development, enabling healthcare providers to have access to various treatments through 3D integrated analysis.

Contact Information

Website
www.cbsbio.com
Formerly Known As
CbsSoft
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, 24, Techno 11-ro
  • Yuseong-gu
  • Daejeon
  • South Korea
+82
Primary Industry
Enterprise Systems (Healthcare)
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 3rd Floor, 24, Techno 11-ro
  • Yuseong-gu
  • Daejeon
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CbsBioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Jan-2011 Completed Clinical Trials - Phase 2
To view CbsBioscience’s complete valuation and funding history, request access »

CbsBioscience Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

CbsBioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230084335-A1 Analysis method for prediction of response to preoperative chemoradiotherapy in rectal cancer patient Pending 21-Feb-2020
US-20230081529-A1 Analysis method for increasing susceptibility to sorafenib treatment in hepatocellular carcinoma Pending 12-Feb-2020
US-20180030541-A1 Method for predicting sensitivity to vascular endothelial growth factor receptor inhibitor Inactive 24-Oct-2014
EP-3211090-A1 Method for predicting sensitivity to vascular endothelial growth factor receptor inhibitor Inactive 24-Oct-2014
EP-3211090-A4 Method for predicting sensitivity to vascular endothelial growth factor receptor inhibitor Inactive 24-Oct-2014 C12Q1/6886
To view CbsBioscience’s complete patent history, request access »

CbsBioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CbsBioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Korea Investment Partners Venture Capital Minority
To view CbsBioscience’s complete investors history, request access »

Ready to get started?

Request a free trial

CbsBioscience FAQs

  • When was CbsBioscience founded?

    CbsBioscience was founded in 2003.

  • Where is CbsBioscience headquartered?

    CbsBioscience is headquartered in Daejeon, South Korea.

  • What is the size of CbsBioscience?

    CbsBioscience has 4 total employees.

  • What industry is CbsBioscience in?

    CbsBioscience’s primary industry is Enterprise Systems (Healthcare).

  • Is CbsBioscience a private or public company?

    CbsBioscience is a Private company.

  • What is CbsBioscience’s current revenue?

    The current revenue for CbsBioscience is .

  • Who are CbsBioscience’s investors?

    Korea Investment Partners has invested in CbsBioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »